Magnitude and determinants of first-time and repeat testing among individuals with newly diagnosed HIV infection between 2000 and 2001 in Alberta, Canada: Results from population-based laboratory surveillance

Journal of Acquired Immune Deficiency Syndromes

Volumn 37, Issue 5, 2004, Pages 1651-1656

  Jayaraman, Gayatri C ^a,d   Bush, Katherine R ^a   Lee, Bonita ^b   Singh, Ameeta E ^c   Preiksaitis, Jutta K ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b Prov Laboratory for Public Health   (Canada)

^c Alberta Health and Wellness ^*  (Canada)

^d PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

Author keywords

Canada; Hepatitis B; Hepatitis C; HIV epidemiology; Laboratory based surveillance; Testing behavior

Indexed keywords

ADOLESCENT; ADULT; AGED; CANADA; CONTROLLED STUDY; DEMOGRAPHY; DISEASE MARKER; DRUG USE; FEMALE; FISHER EXACT TEST; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; MALE; PRIORITY JOURNAL; REVIEW; VIRUS DETECTION;

ADOLESCENT; ADULT; AIDS SERODIAGNOSIS; ALBERTA; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B; HEPATITIS C, CHRONIC; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POPULATION SURVEILLANCE; TIME FACTORS;

EID: 10644289531     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200412150-00020     Document Type: Review

References (26)

1. Valdiserri RO, Holtgrave DR, West GE. Promoting early HIV diagnosis and entry into care. AIDS. 1999;13:2317-2330.
2. Rogheram-Borus MJ, Newman PA, Etzel MA. Effective detection of HIV. J Acquir Immune Defic Syndr. 2000;25:S105-S114.
3. Rosenberg ES, Altfeld M, Poon SH, et al. Immune control of HIV-1 after early treatment of acute infection. Nature. 2000;407:503-526.
4. Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S123-S127.
5. Brocklehurst P, Volmink J. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2002;2:CD003510.
6. Valdiserri RO, Ogden LL, McCray E. Accomplishments in HIV prevention science: implications for stemming the epidemic. Nat Med. 2003;9: 881-886.
7. Houston SM, Archibald CP, Strike C, et al. Factors associated with HIV testing among Canadians: results of a population-based survey. Int J STD AIDS. 1998;9:341-346.
8. MacKellar DA, Valleroy LA, Secura GM, et al. Repeat HIV testing, risk behaviors, and HIV seroconversion among young men who have sex with men: a call to monitor and improve the practice of prevention. J Acquir Immune Defic Syndr. 2002;29:76-85.
9. Weinstock H, Sweeney S, Satten GA, et al. HIV seroincidence and risk factors among patients repeatedly tested for HIV attending sexually transmitted disease clinics in the United States, 1991 to 1996. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19:506-512.
10. Phillips KA, Paul J, Kegeles S, et al. Predictors of repeat HIV testing among gay and bisexual men. AIDS. 1995;9:769-775.
11. McFarland W, Fischer-Ponce L, Katz MH. Repeat negative human immunodeficiency virus (HIV) testing in San Francisco: magnitude and characteristics. Am J Epidemiol. 1995;142:719-723.
12. Calzavara L, Burchell AN, Major C, et al. Increases in HIV incidence among men who have sex with men undergoing repeat diagnostic HIV testing in Ontario, Canada. AIDS. 2002;16:1655-1661.
13. Martinez EH. Hepatitis B and hepatitis C co-infection in patients with HIV Rev Med Virol. 2001;11:253-270.
14. Girardi E, Sampaolesi A, Gentile M, et al. Increasing proportion of late diagnosis of HIV infection among patients with AIDS in Italy following introduction of combination antiretroviral therapy. J Acquir Immune Defic Syndr. 2000;25:71-76.
15. Poznansky MC, Coker R, Skinner C, et al. HIV positive patients first presenting with an AIDS defining illness: characteristics and survival. BMJ. 1995;311:156-158.
16. Gillieatt SJ, Mallal SA, French MAH, et al. Epidemiology of late presentation of HIV infection in Western Australia. Med J of Aust. 1992;157:117-118.
17. Wortley PM, Byers RH, Sweeney PA, et al. HIV testing patterns: where, why, and when were persons with AIDS tested for HIV? AIDS. 1995;9: 487-492.
18. Nakashima AK, Campsmith ML, Wolfe MI, et al. Late versus early testing of HIV: 16 sites, United States, 2000-2003. MMWR. 2003;52:581-586.
19. Geduld J, Romaguera A, Esteve A, et al. Late diagnosis of HIV infection among reported AIDS cases in Canada and Catalonia, Spain. Paper presented at: XIV International AIDS Conference; July 2002; Barcelona, Spain. Proceedings from the XIV International AIDS Conference.
20. Njihia J, Remis RS, Swantee C, et al. Marked increase in first-time diagnoses in Ontario, 2002. Paper presented at: 12th Annual Conference of the Canadian Association for HIV/AIDS Research; April 10-13, 2003; Halifax, Nova Scotia.
21. Hankins C, Alary M, Parent R, et al. Continuing HIV transmission among injection drug users in Eastern Central Canada: the SurvUDI Study, 1995 to 2000. J Acquir Immune Defic Syndr. 2002;30:514-521.
22. Leaity S, Sherr L, Wells H, et al. Repeat HIV testing: high-risk behaviour or risk reduction strategy? AIDS. 2000;14:547-552.
23. Summers T, Spielberg F, Collins C, et al. Voluntary counseling, testing, and referral for HIV: new technologies, research findings create dynamic opportunities. J Acquir Immune Defic Syndr. 2000;25:S128-S135.
24. Alberta Health and Wellness. Surveillance Branch. Alberta Blood-Borne Pathogens Surveillance Report. 2003. Available at: http://www.health.gov.ab.ca/ resources/publications/pdf/BBP03.pdf. Accessed May 17, 2004.
25. Health Canada. HIV and AIDS in Canada. Surveillance Report to June 30, 2003. Division of HIV/AIDS Surveillance and Epidemiology, Centre for Infectious Disease Prevention and Control, Health Canada 2003. Available at: http://www.hc-sc.gc.ca/pphb-dgspsp/publicat/aids-sida/haic-vsac0603/index.html. Accessed May 17, 2004.
26. Jayaraman GC, Preiksaitis JK, Larke B. Mandatory reporting of HIV infection to public health authorities and opt out prenatal screening for HIV in Alberta: effect on testing rates. CMAJ. 2003;168:679-682.